ROYAL BANK OF CANADA - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 168 filers reported holding NEKTAR THERAPEUTICS in Q3 2015. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2023$0100
-73.3%
0.00%
Q2 2023$0
-100.0%
374
-97.0%
0.00%
Q1 2023$8,000
-90.0%
12,344
-65.4%
0.00%
Q4 2022$80,000
+60.0%
35,702
+128.7%
0.00%
Q3 2022$50,000
+56.2%
15,614
+86.4%
0.00%
Q2 2022$32,000
-57.3%
8,378
-39.8%
0.00%
Q1 2022$75,000
+36.4%
13,917
+245.7%
0.00%
Q4 2021$55,000
-81.0%
4,026
-75.0%
0.00%
Q3 2021$290,000
+19.8%
16,127
+14.5%
0.00%
Q2 2021$242,000
+120.0%
14,087
+155.7%
0.00%
Q1 2021$110,000
-60.9%
5,509
-66.7%
0.00%
Q4 2020$281,000
+37.7%
16,529
+34.6%
0.00%
Q3 2020$204,000
-46.5%
12,280
-25.4%
0.00%
Q2 2020$381,000
-59.1%
16,466
-68.5%
0.00%
Q1 2020$932,000
+150.5%
52,241
+203.6%
0.00%
Q4 2019$372,000
-69.7%
17,207
-74.5%
0.00%
Q3 2019$1,229,000
-44.9%
67,487
+7.7%
0.00%
-100.0%
Q2 2019$2,230,000
+22.5%
62,687
+15.7%
0.00%0.0%
Q1 2019$1,821,000
+98.4%
54,185
+94.1%
0.00%
Q4 2018$918,000
-26.5%
27,913
+36.2%
0.00%
-100.0%
Q3 2018$1,249,000
+94.5%
20,500
+55.8%
0.00%
Q2 2018$642,000
-93.9%
13,157
-86.8%
0.00%
-100.0%
Q1 2018$10,597,000
+7362.7%
99,728
+4106.2%
0.01%
Q4 2017$142,000
-59.8%
2,371
-83.9%
0.00%
Q3 2017$353,000
+667.4%
14,706
+524.2%
0.00%
Q2 2017$46,000
-87.5%
2,356
-85.0%
0.00%
Q1 2017$369,000
+74.1%
15,743
-8.4%
0.00%
Q4 2016$212,000
+1666.7%
17,187
+2472.9%
0.00%
Q3 2016$12,000
-96.4%
668
-97.2%
0.00%
Q2 2016$336,000
-84.0%
23,606
-84.6%
0.00%
Q1 2016$2,104,000
+345.8%
152,934
+446.6%
0.00%
Q4 2015$472,000
-11.1%
27,980
-42.2%
0.00%
Q3 2015$531,000
-19.5%
48,420
-8.1%
0.00%
Q2 2015$660,000
+23.8%
52,707
+8.9%
0.00%
Q1 2015$533,000
-32.1%
48,420
-4.3%
0.00%
-100.0%
Q4 2014$785,000
+34.6%
50,589
+4.8%
0.00%
Q3 2014$583,000
-41.7%
48,270
-38.1%
0.00%
-100.0%
Q2 2014$1,000,000
+4.6%
77,970
-1.1%
0.00%0.0%
Q1 2014$956,000
+664.8%
78,858
+616.9%
0.00%
Q4 2013$125,000
+19.0%
11,000
+8.9%
0.00%
Q3 2013$105,000
-37.1%
10,100
-29.9%
0.00%
Q2 2013$167,00014,3990.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2015
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 1,828,400$89,281,0006.61%
Cormorant Asset Management, LP 1,500,000$73,245,0005.42%
Camber Capital Management LP 2,000,000$97,660,0003.76%
Rhenman & Partners Asset Management AB 617,652$30,160,0003.09%
BRIDGER MANAGEMENT, LLC 1,134,414$55,393,0003.00%
First Light Asset Management, LLC 374,251$18,275,0002.84%
Gs Investments, Inc. 54,000$2,636,820,0001.97%
SABBY MANAGEMENT, LLC 241,922$11,813,0001.82%
QUANTRES ASSET MANAGEMENT Ltd 50,000$2,441,0001.41%
Tibra Equities Europe Ltd 173,183$8,457,0001.27%
View complete list of NEKTAR THERAPEUTICS shareholders